November 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 01, 2025
Market insights predict the global pediatric drugs industry will increase from USD 144.88 billion in 2024 to USD 458.09 billion by 2034, achieving a CAGR of 12.2%. Pediatric drugs are medicines specially designed for children to treat illnesses, manage symptoms, or prevent diseases. These drugs consider a child's weight, age, and metabolism to ensu...
November 01, 2025
Projections indicate that, antacids industry is projected to rise from USD 7.47 billion in 2024 to USD 10.33 billion by 2034, reflecting a CAGR of 3.30% over the next decade. The antacids market is growing due to rising acid reflux and GERD cases from sedentary lifestyles, an aging population, and increased R&D for novel formulations. Widely us...
November 01, 2025
Market insights predict the global sports medicine industry will increase from USD 6.28 billion in 2024 to USD 11.90 billion by 2034, achieving a CAGR of 6.6%. In 2024, body reconstruction products dominated with a 41% market share. Knee injuries led demand, making up 32% of the market. North America remained the top region, commanding a 42% share....
November 01, 2025
According to market projections, the retinitis pigmentosa sector is expected to grow from USD 14.89 billion in 2024 to USD 27.17 billion by 2034, reflecting a CAGR of 6.2%. In 2023, Autosomal Recessive RP dominated with 65% market share, but gene therapy is gaining traction at 23%, bringing new hope. North America leads the market, yet Asia Pacific...
November 01, 2025
According to market projections, the ulcerative colitis treatment sector is expected to grow from USD 10.58 billion in 2024 to USD 15.81 billion by 2034, reflecting a CAGR of 4.1%. The battle against ulcerative colitis is heating up! Pancolitis, the most widespread form, accounted for 34% of cases in 2023. Anti-TNF biologics lead treatment options ...
November 01, 2025
Market insights predict the global nanomedicine industry will increase from USD 241.49 billion in 2024 to USD 632.09 billion by 2034, achieving a CAGR of 10.1%. In 2024, North America led the market, while Asia-Pacific is the fastest-growing region. Drug delivery dominated by application, but therapeutics is set for rapid growth. Clinical oncology ...
November 01, 2025
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital pharmacies dominated distribution at 50%. North America was the top region. Key players include ViiV...
November 01, 2025
According to forecasts, the global alopecia areata market will grow from USD 3.32 billion in 2024 to USD 6.92 billion by 2034, with an expected CAGR of 7.6%. AI is transforming the Alopecia Areata market by improving diagnosis, treatment, and research. It enables early detection through advanced analysis, allowing for timely intervention. AI also a...
November 01, 2025
According to market projections, the global multiple sclerosis diagnosis and treatment market, valued at USD 22.89 billion in 2024, is anticipated to reach USD 31.98 billion by 2034, growing at a CAGR of 3.4% over the next decade. Advancements in technology aid early diagnosis and better prevention for multiple sclerosis (MS), reducing its economic...
November 01, 2025
Market insights predict the global cervical spondylosis diagnosis and treatment industry will increase from USD 6.63 billion in 2024 to USD 12.67 billion by 2034, achieving a CAGR of 6.7%. In 2023, medications dominated the Cervical Spondylosis Diagnosis & Treatment Market with a 38% share, while hospital pharmacies led with 40%. The Asia Pacif...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com